Skip to main content

The human microbiome, asthma, and allergy


The human microbiome can be defined as the microorganisms that reside within and on our bodies and how they interact with the environment. Recent research suggests that numerous mutually beneficial interactions occur between a human and their microbiome, including those that are essential for good health. Modern microbiological detection techniques have contributed to new knowledge about microorganisms in their human environment. These findings reveal that the microbiomes of the lung and gut contribute to the pathogenesis of asthma and allergy. For example, evidence indicates that the microbiome of the gut regulates the activities of helper T cell subsets (Th1 and Th2) that affect the development of immune tolerance. Moreover, recent studies demonstrate differences between the lung microbiomes of healthy and asthmatic subjects. The hygiene and biodiversity hypotheses explain how exposure to microorganisms is associated with asthma and allergy. Although those living in developed countries are exposed to fewer and less diverse microorganisms compared with the inhabitants of developing countries, they are experiencing an increase in the incidence of asthma and allergies. Detailed analyses of the human microbiome, as are being conducted under the auspices of the Human Microbiome Project initiated in 2007, promise to contribute insights into the mechanisms and factors that cause asthma and allergy that may lead to the development of strategies to prevent and treat these diseases.


Microbiomes exist in numerous diverse environments such as soil, freshwater, and seawater. The human microbiome was studied for the first time in the 1600s when Antonie van Leeuwenhoek scraped the coating of his teeth and studied the contents using his self-fabricated microscope [1]. Just over 300 years later, the Nobel Laureate Joshua Lederberg coined the term “the human microbiome” to describe the ecological community of symbiotic and pathogenic microorganisms that inhabit the body [2]. Lederberg believed that microorganisms in the human body are significant for health and disease [2]. Scholars distinguish between the concepts of microbiome [3, 4] and microbiota [5] to separate the collective genomes of microorganisms from the microorganisms themselves, although the original definitions do not distinguish between them [35].

An adult human harbors approximately 100 billion bacteria in the intestine alone, and the microbiome accounts for 90 % of the cells in the human body [3]. The human genome comprises about 21,000 genes that encode proteins [6]. In contrast, the microbiome may comprise approximately three million genes [4]. The microbiome may be considered a “new organ system,” because its existence and contributions to human health and disease was uncovered by researchers between 15 and 20 years ago [7]. The composition and function of the microbiome of the human gut evolves during the first years of life and stabilize within the first 3 years of life [810]. The development of the gut microbiome is influenced by interactions between diet, environment, and host- and microbe-associated factors [1018]. The gut microbiome plays a fundamental role in shaping host immunity by balancing the activities of Th-1 cells and Th-2 cells [1923]. In contrast to the extensive knowledge of the gut microbiome [11, 24], information on the lung microbiome is limited [25, 26]. However evidence suggests a distinct microbiome of the lungs of healthy subjects [27] and a difference between the microbiomes of healthy people and those with obstructive lung diseases such as asthma [28].

The aim of the present review was to provide a general account of current research on the gut and lung microbiomes of humans and their association with the pathogenesis of allergy and asthma.


The human microbiome

Over the last 30 years, the development of techniques to sequence microbial ribosomal RNA genes has led to the reconstruction of the evolutionary history of microorganisms [29, 30] and the illumination of their ecology. The United States National Institutes of Health initiated the Human Microbiome Project (HMP), which was allocated a budget of 150 million USD to investigate the microbiota of the human nose, mouth, gut, skin, and genitourinary tract with the aim of documenting the changes in the microbiome associated with human health [4]. Contributions of the HMP include the discovery that the microbiomes of the anatomic sites described above are similar among individuals but vary between the hair, nose, mouth, gut, skin, and genitourinary tract [24]. However, there may be large individual variations in microbiomes at the same sites on the body among individual [31].

The gut microbiome

The most thoroughly studied microbiome is that of the human gut [26]. Swift adaptation to modern lifestyles and environmental transitions likely changed the human gut microbiome with clear effects on immunological and physiological processes that affect human health [11]. The stability and diversity of the gut microbiome increase over the first 3 years of life [810]. Perinatal exposure [14], gestational age [16], mode of delivery [12], host genetics [15], and breastfeeding [10, 13] influence the development of the microbiomes of infants while antibiotics [18] and diet may also influence the microbiomes of older people [17]. Firmicutes and Bacteroidetes dominate the gut microbiome of adults; however, the representation and diversity of different classes of bacteria vary enormously [4].

A recent study of fecal samples of 124 European subjects identified between 1000 and 1150 bacterial species. Each individual in the cohort harbored at least 160 bacterial species, many of which were shared [32]. Knowledge gained from research on the gut microbiome provides insight into the development of allergic diseases and why the far less studied lung microbiome may contribute to the development of asthma. Factors such as birth by cesarean section [12, 33], breastfeeding [33], introduction of solid foods [10], and use of antibiotics by the mother or infant [34] affect the gut microbiome and are associated with increased incidences of asthma and allergies [35]. For example in a study including 2733 1-month-old infants, colonization of with Clostridium difficile is associated with birth by cesarean section and an increase in the risk of asthma (aOR = 2.06) at 6 years of age [36]. However, there are great inconsistencies in the findings of studies on the association between delivery by caesarian section and proven food allergy [37].

However, there is persuasive evidence indicating that children born by cesarean section have twice the risk of being sensitized to egg and milk allergens [38]. A recent study [40] of the association between gut microbiota and food sensitization in the first year of life among 166 infants found that 7.2 % were sensitized to one or more food allergens at 1 year of age and had lower gut microbiota richness and an elevated Enterobacteriaceae:Bacterioidaceae ratio. These findings suggest that early gut colonization may contribute to the development of atopic diseases such as food allergy [39]. Interaction between the host and the gut microbiome may explain the relationship between the microbiome and asthma and allergies.

Studies conducted using mice show that the gut microbiome is important in shaping the host’s immune system [23]. Mice with different genetic predispositions to polarize responses to different antigens in opposite directions, toward either Th1 cells (possibly suppressed in asthma and allergy [40]) or Th2 cells (enhanced in asthma and allergy [40]) depending on the stimulus, both have airway response when the microbiome is disrupted [41]. By controlling the activation of antigen-presenting dendritic cells in the gut, single bacterial species may regulate the differentiation of naïve T cells into regulatory T cells [20]. The microbiome may affect the balance between Th1 cells and Th2 cells and thus the outcomes of subsequent infections with pathogens [20]. This is just one of many examples of immune regulation in symbiosis with bacteria [17, 19]. Further, specific bacterial species directly influence the development of regulatory T cells in mice [21] and humans [22]. Thus, symbiotic bacteria may regulate the immune system.

The lung microbiome

Researchers believed mistakenly for many years that the lungs are sterile [42]. For example, in a study of 28 healthy adults, the most common phyla detected in the nose and oropharynx are Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria and that 2000 bacterial genomes per cm2 are present in the upper left lobe of the lung [26]. Proteobacteria, particularly Haemophilus spp., are more common in the lungs of asthmatic adults than in those of healthy controls who harbor a higher proportion of Bacteroidetes. Further, the abundance of Proteobacteria in asthmatic children is higher compared with healthy controls [28].

In children with asthma, the bacterial load is significantly higher in the lung compared with healthy controls [44]. Further, Airway microbiological diversity in the lungs was significantly greater in asthmatic children who demonstrated significant reduction in bronchial responsiveness after antibiotic treatment [43]. Six weeks of treatment of patients with asthma with azithromycin reduces the relative abundance of Prevotella from 4.54 to 3.43 %, Staphylococcus from 10.49 to 4.59 %, and Haemophilus from 10.74 to 3.28 %. In some patients treatment with azithromycin reduces the bacterial richness in the airways and Anaerococcus becomes the most abundant bacteria. [44]. Further research is required to understand the role of the lung microbiome in the pathogenesis of asthma.

The microbiome in allergy and asthma

Increasing evidence suggests that the compositions of the lung and gut microbiomes determine the risk of asthma and allergies. It is interesting to consider how these findings support or contradict the “hygiene” and “biodiversity” hypotheses (see below) that were proposed to account for the influence of the human microbiota on allergies and immune tolerance. The hygiene hypothesis argues that the lack of early exposure to infectious agents, symbiotic microorganisms (such as intestinal flora and probiotics), and parasites increases susceptibility to allergic diseases through insufficient stimulation of Th1 cells [45], which cannot counterbalance the effects of Th2 cells, leading to predisposition to allergic diseases [20]. The biodiversity hypothesis suggests that disturbances in the composition of the gut microbiome of citizens of western countries induced by antibiotics, diet, and lifestyle disrupt the mechanisms of mucosal immunological tolerance [46]. The biodiversity hypothesis extends the hygiene hypothesis by stating that the gut microbiome interacts with the immune system to maintain the efficiency of the immune system [47].

The hygiene hypothesis

The hygiene hypothesis was proposed to explain the invers association between the risk of hay fever and the number of older siblings [46]. Thus, infections in early childhood transmitted through unhygienic contact with older siblings, or through the mother who is infected by her older children, prevent the development of allergic disease [45]. This hypothesis is supported by the findings of a study on school children in areas of Germany that were formerly East and West Germany that showed a decreased risk of allergic sensitization with an increasing number of older siblings, which was indicated by a rate of allergic sensitization this was three times higher in the former West compared with East Germany [48]. Numerous subsequent cross-sectional studies support the hygiene hypothesis, because they show that increased exposure to bacteria, fungi, airway infections, dogs, cats, and other animals in childhood is associated with decreased risk of asthma and allergies [49, 50]. Other studies show a lower incidence of allergic diseases in children raised on farms [51].

The hygiene hypothesis has been “updated” based on cross-sectional data together with experimental data and can be reconciled by a “new hygienic hypothesis” or a “Western lifestyle hypothesis,” [52] which proposes that Th1 cells are not stimulated to balance the Th2 cells. Imbalance in the Th2 cell population leads to the production of interleukins (IL-4 and IL-5), which then induce the production IgE and eosinophils that cause atopic disease [53]. The relationship between exposure to different types of bacteria or fungi and asthma in children was assessed in a review of the characteristics of more than 15,000 children included in two different studies [50]. This analysis found that children who lived on a farm are exposed to diverse microflora compared to children not living on farms. The two studies analyzed show a reduced prevalence of asthma in children who live on a farm compared children not living on farms and an inverse association between exposure to microbes and the probability of asthma. However, a correlation between exposure to the microbiota and antigen-specific IgE was not detected [49].

Because cross-sectional studies simultaneously measure exposure and effect, they cannot establish a causal relationship. For example, the findings of cross-sectional studies may be explained if the parents of children with atopic disease have fewer children compared with other parents. Thus, the lower incidence of asthma and allergies in people who live on farms may be explained by families with asthma who discontinue farming and move; in contrast, healthy families continue to farm. Such an effect is called the healthy worker effect [54]. Occupational epidemiology studies suggest that the healthy worker effect reduces the association between exposure and outcome by 20–30 % [55] and that the effect of “cat avoidance” could correspond to a protective effect with an odds ratio of 0.83 [56]. Several longitudinal studies did not detect similar effects that support the hygiene hypothesis [57, 58], and several studies of birth cohorts show an positive association between exposure to cats and cat allergen-specific IgE [59, 60]. Other observations such as increased atopy in poor and densely populated urban areas and among children in kindergarten argue against the hygiene hypothesis [61].

The biodiversity and the microflora hypotheses

Biodiversity is important for human livelihood and development and plays a paramount role in the quality of life of populations worldwide [62]. Moreover, the loss of biodiversity may have serious implications for human health [63]. Evidence indicates that the diversity of the body’s microbiota is negatively associated with the risk of developing asthma and allergy [46, 64]. The biodiversity and disappearing microbiota hypotheses argue that changes in how people interact with the environment reduces exposure to microorganisms and that this may affect the mechanisms of development of immunologic tolerance [46, 65]. For example, consumption by mothers and infants of untreated cow’s milk is negatively associated with asthma and allergies in children regardless of whether they live on a farm [66]. Further, a diverse intestinal flora in early life is associated with reduced risk of allergy at 5 years of age [67], and the diversity of gram-negative Gammaproteobacteria, common in soil but particularly dominant in aboveground vegetation, is reduced on the skin the atopic adolescents [68]. The association of gram-negative Gammaproteobacteria such as Acinetobacter with atopic disease is supported by the positive correlation of the levels of a regulator of immune tolerance, IL-10, with the abundance of Acinetobacter on the skin of healthy but not atopic adolescents [68].

The microflora hypothesis extends the hygiene and biodiversity hypotheses by proposing that the gut microbiome interacts with the immune system to maintain immune function. An imbalance in the gut microbiome caused by changes in the use of antibiotics and in the diet over the last three decades may cause dysfunction of the immune system [47]. This may explain why diseases such as asthma and allergy develop at any age. The evidence supporting the microflora hypothesis includes the increased incidences of asthma and allergies in industrialized countries during the last 50 years [69, 70] and includes the major relationships as follows: (1) correlation between allergic diseases and antibiotic use [71, 72], (2) correlation between allergic diseases and altered fecal microbiota [73, 74], and (3) correlation between allergic diseases and dietary changes [75]. Studies of mice demonstrate that antibiotic treatment that disrupts the microbiome may inhibit airway tolerance to airborne allergens such as fungal spores (e.g. Aspergillus fumigatus) [76] or aerosolized ovalbumin [41].


Probiotics are defined as viable microorganisms that enhance the host’s health [77]. There is great uncertainty about the efficacy of probiotics for preventing and treating asthma and allergies. For example, when Lactobacillus was administered prenatally to mothers with at least one relative or partner with allergic rhinitis, atopic eczema, or asthma, and postnatally for 6 months to their infants, the outcome indicated a promising effect on the prevention of atopic disease [78]; however, the results of more recent studies (mainly of Lactobacillus and Bifidobacterium) are inconsistent [79]. A meta-analysis of 25 studies that assessed the effects of probiotic administration in children on atopy and asthma found that administration of probiotics reduces IgE levels and the risk of atopic sensitization but not the risk of asthma or wheezing [80]. The timing of ingestion, prenatally to the mother and postnatally to the infant versus postnatally to only the infant, did not influence IgE levels; however, the risk of allergic sensitization was significantly reduced only when the administration of probiotics commenced prenatally and continued after birth. The decrease in total IgE was more pronounced when probiotics were administered for longer, and the reduced risk of allergic sensitization may therefore depend on the specific bacterial strains. These findings indicate that administration of probiotics during pregnancy and to infants may contribute to the prevention of atopic diseases in high-risk infants [80].

Bacterial products may have great potential for preventing and treating allergies, although the bacterial species, their numbers, and the duration and timing of treatment that are safe and effective are unknown [46]. The results of a controlled clinical trial of newborns indicate that 6 months of treatment with oral probiotics protects against IgE-associated dermatitis at 2 years, but only for those at high risk of eczema. The effect disappears after 5 years of age [81]. Future probiotic supplements are likely to contain a wide range of microbes that can have long-term beneficial effects on the immune system [82]. Therefore, immunological, epidemiological, microbiological, and clinical studies are required to establish whether supplementation with bacterial products contribute to effective treatment and prevention of asthma and allergy. Future trials investigating the effects of probiotics should include analyses of specific strains of probiotic bacteria and longer follow-up.

Areas for future exploration

Allergy and asthma are heterogeneous diseases but are categorized according to an increased tendency of inflammation driven by changes in the environment, nutrition, the gut microbiome, and possibly the lung microbiome. The outcome of these changes may depend on genotype [83, 84], overall biodiversity [46], and other risk factors such as physical activity [85] and air pollution [86]. The findings may contribute a common explanation of why the incidence of numerous inflammatory conditions such as asthma and allergy has increased in parallel with changes in the environment [11]. A broad interdisciplinary approach will be required to understand the complex pathogenesis of asthma and allergy and to understand the roles of the lung and gut microbiomes. The use of standardized outcomes and methodology may help address the gaps in our knowledge [11, 87]. For example, researchers should continue to focus on the functional and ecologic characteristics of the gut and lung microbiomes of healthy people as well as the features of the lung and gut microbiomes of patients with specific diseases. The development of strategies to improve microbiome colonization patterns will likely enhance health throughout an individual’s life. It will be necessary to determine if variations in the microbiome are the cause or effect of allergies and asthma, and longitudinal studies are essential to control for different confounding factors. Further research on the microbiome should include organisms other than bacteria as some viruses [88] and fungi [89] interact with their hosts cells similar to what’s observed with bacteria and their host. The results of such research can be ultimately translated to the clinic to improve diagnostics as well as treatment and prevention strategies that might include probiotics as well as dietary and lifestyle interventions.


The microbiome can be defined as all microorganisms that inhabit humans and their interactions with the environment. The findings of studies employing recently developed techniques such as metagenomics as well as those of epidemiological studies indicate that humans are exposed to fewer microorganisms because of changes in factors such as the use of antibiotics and diet, which are accompanied by increasing susceptibility to asthma and allergies. Moreover, these studies illuminate the differences in the microbiomes of healthy people and those with asthma and allergies. Moreover, they show that early exposure to bacteria may protect against these diseases. Further basic studies are required to characterize the lung and the gut microbiomes of healthy people was well as those with asthma and allergies. The ultimate goal is to understand whether aspects of the microbiome are linked to disease and whether manipulation of the microbiome will be useful to preserve lung function, prevent, and treat allergies.


  1. 1.

    Dobell C. Antony Van Leeuwenhoek and his little animals. New York: Brace and Company; 1932.

    Google Scholar 

  2. 2.

    Lederberg J, Mccray A. Ome Sweet’Omics—a genealogical treasury of words. Scientist. 2001;15(8).

  3. 3.

    Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124(4):837–48. doi:10.1016/j.cell.2006.02.017.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804–10. doi:10.1038/nature06244.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  5. 5.

    Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915–20. doi:10.1126/science.1104816.

    PubMed  Article  Google Scholar 

  6. 6.

    Pennisi E. Genomics. ENCODE project writes eulogy for junk DNA. Science. 2012;337(6099):1159. doi:10.1126/science.337.6099.1159.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Plotnikoff GA, Riley D. The human microbiome. Glob Adv Health Med. 2014;3(3):4–5.

    PubMed Central  PubMed  Article  Google Scholar 

  8. 8.

    Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30. doi:10.1038/nature11550.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  9. 9.

    Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4578–85. doi:10.1073/pnas.1000081107.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  10. 10.

    Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–7. doi:10.1038/nature11053.

    PubMed Central  CAS  PubMed  Google Scholar 

  11. 11.

    West CE, Renz H, Jenmalm MC, Kozyrskyj AL, Allen KJ, Vuillermin P, et al. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol. 2015;135(1):3–13. doi:10.1016/j.jaci.2014.11.012 (quiz 4).

    PubMed  Article  Google Scholar 

  12. 12.

    Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107(26):11971–5. doi:10.1073/pnas.1002601107.

    PubMed Central  PubMed  Article  Google Scholar 

  13. 13.

    Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30(1):61–7.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Jimenez E, Marin ML, Martin R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;159(3):187–93. doi:10.1016/j.resmic.2007.12.007.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Li M, Wang M, Donovan SM. Early development of the gut microbiome and immune-mediated childhood disorders. Semin Reprod Med. 2014;32(1):74–86. doi:10.1055/s-0033-1361825.

    PubMed  Article  Google Scholar 

  16. 16.

    Magne F, Abely M, Boyer F, Morville P, Pochart P, Suau A. Low species diversity and high interindividual variability in faeces of preterm infants as revealed by sequences of 16S rRNA genes and PCR-temporal temperature gradient gel electrophoresis profiles. FEMS Microbiol Ecol. 2006;57(1):128–38. doi:10.1111/j.1574-6941.2006.00097.x.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–23. doi:10.1038/nri2515.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  18. 18.

    Tanaka S, Kobayashi T, Songjinda P, Tateyama A, Tsubouchi M, Kiyohara C, et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol. 2009;56(1):80–7. doi:10.1111/j.1574-695X.2009.00553.x.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–98. doi:10.1016/j.cell.2009.09.033.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  20. 20.

    McLoughlin RM, Mills KH. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol. 2011;127(5):1097–107. doi:10.1016/j.jaci.2011.02.012 (quiz 108–9).

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    O’Mahony C, Scully P, O’Mahony D, Murphy S, O’Brien F, Lyons A, et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog. 2008;4(8):e1000112. doi:10.1371/journal.ppat.1000112.

    PubMed Central  PubMed  Article  Google Scholar 

  22. 22.

    de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, et al. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2010;40(1):103–10. doi:10.1111/j.1365-2222.2009.03344.x.

    Google Scholar 

  23. 23.

    Ostman S, Rask C, Wold AE, Hultkrantz S, Telemo E. Impaired regulatory T cell function in germ-free mice. Eur J Immunol. 2006;36(9):2336–46. doi:10.1002/eji.200535244.

    PubMed  Article  Google Scholar 

  24. 24.

    Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–70. doi:10.1038/nrg3182.

    PubMed Central  CAS  PubMed  Google Scholar 

  25. 25.

    Cui L, Morris A, Huang L, Beck JM, Twigg HL 3rd, von Mutius E, et al. The microbiome and the lung. Ann Am Thorac Soc. 2014;11(Suppl 4):S227–32. doi:10.1513/AnnalsATS.201402-052PL.

    PubMed Central  PubMed  Article  Google Scholar 

  26. 26.

    The Human microbiome Project, Dataset. Accessed 30 June 2015.

  27. 27.

    Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013;187(10):1067–75. doi:10.1164/rccm.201210-1913OC.

    PubMed Central  PubMed  Article  Google Scholar 

  28. 28.

    Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5(1):e8578. doi:10.1371/journal.pone.0008578.

    PubMed Central  PubMed  Article  Google Scholar 

  29. 29.

    Amann RI, Ludwig W, Schleifer KH. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev. 1995;59(1):143–69.

    PubMed Central  CAS  PubMed  Google Scholar 

  30. 30.

    Ciccarelli FD, Doerks T, von Mering C, Creevey CJ, Snel B, Bork P. Toward automatic reconstruction of a highly resolved tree of life. Science. 2006;311(5765):1283–7. doi:10.1126/science.1123061.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Consortium THMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14.

  32. 32.

    Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  33. 33.

    Penders J, Gerhold K, Stobberingh EE, Thijs C, Zimmermann K, Lau S et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol. 2013;132(3):601–7 e8. doi:10.1016/j.jaci.2013.05.043.

  34. 34.

    Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes. 2012;3(3):203–20. doi:10.4161/gmic.20169.

    PubMed Central  PubMed  Article  Google Scholar 

  35. 35.

    Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118(2):511–21. doi:10.1542/peds.2005-2824.

    PubMed  Article  Google Scholar 

  36. 36.

    van Nimwegen FA, Penders J, Stobberingh EE, Postma DS, Koppelman GH, Kerkhof M et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol. 2011;128(5):948–55.e1–3. doi:10.1016/j.jaci.2011.07.027.

  37. 37.

    Molloy J, Allen K, Collier F, Tang ML, Ward AC, Vuillermin P. The potential link between gut microbiota and IgE-mediated food allergy in early life. Int J Environ Res Public Health. 2013;10(12):7235–56. doi:10.3390/ijerph10127235.

    PubMed Central  PubMed  Article  Google Scholar 

  38. 38.

    Koplin J, Allen K, Gurrin L, Osborne N, Tang ML, Dharmage S. Is caesarean delivery associated with sensitization to food allergens and IgE-mediated food allergy: a systematic review. Pediatric Allergy Immunol Off Publ Eur Soc Pediatric Allergy Immunol. 2008;19(8):682–7. doi:10.1111/j.1399-3038.2008.00731.x.

    Article  Google Scholar 

  39. 39.

    Azad MB, Konya T, Guttman DS, Field CJ, Sears MR, HayGlass KT, et al. Infant gut microbiota and food sensitization: associations in the first year of life. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2015;45(3):632–43. doi:10.1111/cea.12487.

    CAS  Article  Google Scholar 

  40. 40.

    Ngoc PL, Gold DR, Tzianabos AO, Weiss ST, Celedon JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol. 2005;5(2):161–6.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun. 2005;73(1):30–8. doi:10.1128/IAI.73.1.30-38.2005.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  42. 42.

    Baughman RP, Thorpe JE, Staneck J, Rashkin M, Frame PT. Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest. 1987;91(2):233–6.

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011;127(2):372–81e1–3. doi:10.1016/j.jaci.2010.10.048.

  44. 44.

    Slater M, Rivett DW, Williams L, Martin M, Harrison T, Sayers I, et al. The impact of azithromycin therapy on the airway microbiota in asthma. Thorax. 2014;69(7):673–4. doi:10.1136/thoraxjnl-2013-204517.

    PubMed Central  PubMed  Article  Google Scholar 

  45. 45.

    Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259–60.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  46. 46.

    Haahtela T, Holgate S, Pawankar R, Akdis CA, Benjaponpitak S, Caraballo L, et al. The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Org J. 2013;6(1):3. doi:10.1186/1939-4551-6-3.

    Article  Google Scholar 

  47. 47.

    Noverr MC, Huffnagle GB. The ‘microflora hypothesis’ of allergic diseases. Clin Exp allergy J Br Soc Allergy Clin Immunol. 2005;35(12):1511–20. doi:10.1111/j.1365-2222.2005.02379.x.

    CAS  Article  Google Scholar 

  48. 48.

    von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Reitmeir P, Thiemann HH. Skin test reactivity and number of siblings. BMJ. 1994;308(6930):692–5.

    Article  Google Scholar 

  49. 49.

    Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson WO, Braun-Fahrlander C, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701–9. doi:10.1056/NEJMoa1007302.

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(2):187–93.

    Article  Google Scholar 

  51. 51.

    von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010;10(12):861–8. doi:10.1038/nri2871.

    Article  Google Scholar 

  52. 52.

    Okada H, Kuhn C, Feillet H, Bach JF. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol. 2010;160(1):1–9. doi:10.1111/j.1365-2249.2010.04139.x.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  53. 53.

    Holt PG, Sly PD. Prevention of allergic respiratory disease in infants: current aspects and future perspectives. Curr Opin Allergy Clin Immunol. 2007;7(6):547–55. doi:10.1097/ACI.0b013e3282f14a17.

    PubMed  Article  Google Scholar 

  54. 54.

    McMichael AJ. Standardized mortality ratios and the “healthy worker effect”: scratching beneath the surface. J Occup Med. 1976;18(3):165–8.

    CAS  PubMed  Article  Google Scholar 

  55. 55.

    Shah D. Healthy worker effect phenomenon. Indian J Occupational and Env Med. 2009;13(2):77–9. doi:10.4103/0019-5278.55123.

    Article  Google Scholar 

  56. 56.

    Svanes C, Zock JP, Anto J, Dharmage S, Norback D, Wjst M, et al. Do asthma and allergy influence subsequent pet keeping? An analysis of childhood and adulthood. J Allergy Clin Immunol. 2006;118(3):691–8. doi:10.1016/j.jaci.2006.06.017.

    PubMed  Article  Google Scholar 

  57. 57.

    Ghosh RE, Cullinan P, Fishwick D, Hoyle J, Warburton CJ, Strachan DP, et al. Asthma and occupation in the 1958 birth cohort. Thorax. 2013;68(4):365–71. doi:10.1136/thoraxjnl-2012-202151.

    PubMed  Article  Google Scholar 

  58. 58.

    Rask-Andersen A. Asthma increase among farmers: a 12-year follow-up. Upsala J Med Sci. 2011;116(1):60–71. doi:10.3109/03009734.2010.503287.

    PubMed Central  PubMed  Article  Google Scholar 

  59. 59.

    Chen CM, Rzehak P, Zutavern A, Fahlbusch B, Bischof W, Herbarth O, et al. Longitudinal study on cat allergen exposure and the development of allergy in young children. J Allergy Clin Immunol. 2007;119(5):1148–55. doi:10.1016/j.jaci.2007.02.017.

    CAS  PubMed  Article  Google Scholar 

  60. 60.

    Torrent M, Sunyer J, Munoz L, Cullinan P, Iturriaga MV, Figueroa C, et al. Early-life domestic aeroallergen exposure and IgE sensitization at age 4 years. J Allergy Clin Immunol. 2006;118(3):742–8. doi:10.1016/j.jaci.2006.04.059.

    CAS  PubMed  Article  Google Scholar 

  61. 61.

    Crater DD, Heise S, Perzanowski M, Herbert R, Morse CG, Hulsey TC, et al. Asthma hospitalization trends in Charleston, South Carolina, 1956 to 1997: twenty-fold increase among black children during a 30-year period. Pediatrics. 2001;108(6):E97.

    CAS  PubMed  Article  Google Scholar 

  62. 62.

    Sen T, Samanta SK. Medicinal plants, human health and biodiversity: a broad review. Adv Biochem Eng Biotechnol. 2015;147:59–110. doi:10.1007/10_2014_273.

    PubMed  Google Scholar 

  63. 63.

    Butkus M. All health is local: biodiversity, ethics, and human health. Ethics Policy Environ. 2015;18(1):1–15. doi:10.1080/21550085.2015.1016969.

    Article  Google Scholar 

  64. 64.

    Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis. 2008;198(4):553–60. doi:10.1086/590158.

    PubMed Central  PubMed  Article  Google Scholar 

  65. 65.

    Blaser MJ. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res. 2008;1(5):308–11. doi:10.1158/1940-6207.CAPR-08-0170.

    Article  Google Scholar 

  66. 66.

    Wlasiuk G, Vercelli D. The farm effect, or: when, what and how a farming environment protects from asthma and allergic disease. Curr Opin Allergy Clin Immunol. 2012;12(5):461–6. doi:10.1097/ACI.0b013e328357a3bc.

    PubMed  Article  Google Scholar 

  67. 67.

    Sjogren YM, Jenmalm MC, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2009;39(4):518–26. doi:10.1111/j.1365-2222.2008.03156.x.

    CAS  Article  Google Scholar 

  68. 68.

    Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci USA. 2012;109(21):8334–9. doi:10.1073/pnas.1205624109.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  69. 69.

    Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009;64(6):476–83. doi:10.1136/thx.2008.106609.

    CAS  PubMed  Article  Google Scholar 

  70. 70.

    Pawankar R, Baena-Cagnani CE, Bousquet J, Canonica GW, Cruz AA, Kaliner MA, et al. State of world allergy report 2008: allergy and chronic respiratory diseases. World Allergy Org J. 2008;1(6 Suppl):S4–17. doi:10.1097/WOX.0b013e31817ff995.

    Google Scholar 

  71. 71.

    Droste JH, Wieringa MH, Weyler JJ, Nelen VJ, Vermeire PA, Van Bever HP. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(11):1547–53.

    CAS  Article  Google Scholar 

  72. 72.

    McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol. 2002;109(1):43–50.

    PubMed  Article  Google Scholar 

  73. 73.

    Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 1999;29(3):342–6.

    CAS  Article  Google Scholar 

  74. 74.

    Bottcher MF, Nordin EK, Sandin A, Midtvedt T, Bjorksten B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(11):1590–6.

    CAS  Article  Google Scholar 

  75. 75.

    Julia V, Macia L, Dombrowicz D. The impact of diet on asthma and allergic diseases. Nat Rev Immunol. 2015;15(5):308–22. doi:10.1038/nri3830.

    CAS  PubMed  Article  Google Scholar 

  76. 76.

    Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun. 2004;72(9):4996–5003. doi:10.1128/iai.72.9.4996-5003.2004.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  77. 77.

    Sanders ME. Probiotics: definition, sources, selection, and uses. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008;46(Suppl 2):S58–61; discussion S144–51. doi:10.1086/523341.

  78. 78.

    Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357(9262):1076–9. doi:10.1016/S0140-6736(00)04259-8.

    CAS  PubMed  Article  Google Scholar 

  79. 79.

    Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, Cocco R, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a world allergy organization position paper. World Allergy Org J. 2012;5(11):148–67. doi:10.1097/WOX.0b013e3182784ee0.

    Article  Google Scholar 

  80. 80.

    Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics. 2013;132(3):e666–76. doi:10.1542/peds.2013-0246.

    PubMed  Article  Google Scholar 

  81. 81.

    Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123(2):335–41. doi:10.1016/j.jaci.2008.11.019.

    PubMed  Article  Google Scholar 

  82. 82.

    Savilahti E, Kukkonen K, Kuitunen M. Probiotics in the treatment and prevention of allergy in children. World Allergy Org J. 2009;2(5):69–76. doi:10.1097/WOX.0b013e3181a45ee5.

    Article  Google Scholar 

  83. 83.

    Hanson M, Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD. Developmental plasticity and developmental origins of non-communicable disease: theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol. 2011;106(1):272–80. doi:10.1016/j.pbiomolbio.2010.12.008.

    PubMed  Article  Google Scholar 

  84. 84.

    Ke X. Presence of multiple independent effects in risk loci of common complex human diseases. Am J Hum Genet. 2012;91(1):185–92. doi:10.1016/j.ajhg.2012.05.020.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

  85. 85.

    Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol. 2005;78(4):819–35. doi:10.1189/jlb.0505247.

    CAS  PubMed  Article  Google Scholar 

  86. 86.

    D’Amato G, Liccardi G, D’Amato M, Holgate S. Environmental risk factors and allergic bronchial asthma. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2005;35(9):1113–24. doi:10.1111/j.1365-2222.2005.02328.x.

    Article  Google Scholar 

  87. 87.

    Huang YJ, Boushey HA. The microbiome and asthma. Ann Am Thorac Soc. 2014;11(Suppl 1):S48–51. doi:10.1513/AnnalsATS.201306-187MG.

    PubMed Central  PubMed  Article  Google Scholar 

  88. 88.

    Prangishvili D. The wonderful world of archaeal viruses. Annu Rev Microbiol. 2013;67:565–85. doi:10.1146/annurev-micro-092412-155633.

    CAS  PubMed  Article  Google Scholar 

  89. 89.

    Huffnagle GB, Noverr MC. The emerging world of the fungal microbiome. Trends Microbiol. 2013;21(7):334–41. doi:10.1016/j.tim.2013.04.002.

    PubMed Central  CAS  PubMed  Article  Google Scholar 

Download references


The author is the only contributor to the manuscript and received no funding for the present review.

Competing interests

The author has no competing interests.

Author information



Corresponding author

Correspondence to Amund Riiser.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Riiser, A. The human microbiome, asthma, and allergy. Allergy Asthma Clin Immunol 11, 35 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Asthma
  • Allergy
  • Microbiome